XML 15 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Cash flows from operating activities:      
Net loss $ (43,205) $ (46,507)  
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 521 508  
Stock-based compensation 6,519 8,283  
Amortization of premiums and discounts on marketable securities (2,902) (3,532)  
Amortization of debt discount and issuance costs and other non-cash interest 129 118  
Impairment loss of right-of-use asset 1,549 0 $ 2,700
Changes in operating assets and liabilities      
Prepaid expenses and other current assets 2,143 2,246  
Other assets (927) (5,888)  
Accounts payable, accrued and other current liabilities (3,106) 2,453  
Operating lease asset and liabilities (614) (141)  
Net cash used in operating activities (39,893) (42,460)  
Cash flows from investing activities:      
Purchases of property and equipment 0 (1,673)  
Purchases of marketable securities (52,126) (95,233)  
Maturities of marketable securities 84,750 126,500  
Net cash provided by investing activities 32,624 29,594  
Cash flows from financing activities:      
Proceeds from issuance of common stock under employee stock incentive plans 56 536  
Net cash provided by financing activities 56 536  
Effect of exchange rate changes on cash and cash equivalents (4) (17)  
Net decrease in cash and cash equivalents (7,217) (12,347)  
Cash and cash equivalents at the beginning of period 35,493 40,456 40,456
Cash and cash equivalents at the end of period 28,276 28,109 $ 35,493
Supplemental disclosures of noncash investing and financing information:      
Purchases of property and equipment in accounts payable 0 117  
Par value of common stock upon cashless exercise of prefunded warrants 0 4  
Supplemental disclosures      
Cash paid for interest $ 672 $ 637